Vireo Growth (VREOF) Operating Leases (2020 - 2026)
Vireo Growth (VREOF) posted Operating Leases of $174.4 million for Q1 2026, up 19.21% sequentially from $146.3 million in Q4 2025, and up 961.0% YoY from $16.4 million in Q1 2025.
Vireo Growth (VREOF) Operating Leases (2020 - 2026) Analysis & Trends
Vireo Growth has reported Operating Leases for 7 years, with the latest figure at $174.4 million in Q1 2026.
- Quarterly Operating Leases rose 961.0% year-over-year to $174.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $174.4 million (up 961.0% YoY) and the FY2025 annual result came in at $146.3 million, up 786.97% from the prior year.
- Operating Leases advanced to $174.4 million in Q1 2026 per VREOF's latest filing, from $146.3 million in the prior quarter.
- Over five years, Operating Leases peaked at $174.4 million in Q1 2026 and troughed at $9.7 million in Q2 2023.
- A 5-year average of $50.5 million and a median of $19.6 million in 2024 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2023 and 2026: Operating Leases plunged 88.01% in 2023, then surged 961.0% in 2026.
- Over 5 years, Operating Leases stood at $79.8 million in 2022, then slumped by 86.78% to $10.5 million in 2023, then surged by 56.44% to $16.5 million in 2024, then surged by 786.97% to $146.3 million in 2025, then increased by 19.21% to $174.4 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $174.4 million, $146.3 million, and $41.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Vireo Growth | 482.88 Mn | 340.58 Mn | 95.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 174.40 Mn |
| Dec 31, 2025 | 146.30 Mn |
| Sep 30, 2025 | 41.77 Mn |
| Jun 30, 2025 | 43.19 Mn |
| Mar 31, 2025 | 16.44 Mn |
| Dec 31, 2024 | 16.49 Mn |
| Sep 30, 2024 | 19.05 Mn |
| Jun 30, 2024 | 19.47 Mn |
| Mar 31, 2024 | 19.64 Mn |
| Dec 31, 2023 | 10.54 Mn |
| Sep 30, 2023 | 9.70 Mn |
| Jun 30, 2023 | 9.67 Mn |
| Mar 31, 2023 | 10.37 Mn |
| Dec 31, 2022 | 79.76 Mn |
| Sep 30, 2022 | 80.88 Mn |
| Jun 30, 2022 | 80.45 Mn |
| Mar 31, 2022 | 79.92 Mn |
| Dec 31, 2021 | 80.23 Mn |
| Sep 30, 2021 | 78.61 Mn |
| Jun 30, 2021 | 21.79 Mn |